NO853241L - Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse - Google Patents

Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse

Info

Publication number
NO853241L
NO853241L NO853241A NO853241A NO853241L NO 853241 L NO853241 L NO 853241L NO 853241 A NO853241 A NO 853241A NO 853241 A NO853241 A NO 853241A NO 853241 L NO853241 L NO 853241L
Authority
NO
Norway
Prior art keywords
cells
compounds
hydrogen
cell
cdm
Prior art date
Application number
NO853241A
Other languages
English (en)
Norwegian (no)
Inventor
Adam Kovacs
Original Assignee
Adam Kovacs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adam Kovacs filed Critical Adam Kovacs
Publication of NO853241L publication Critical patent/NO853241L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO853241A 1983-12-20 1985-08-16 Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse NO853241L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU834348A HU200093B (en) 1983-12-20 1983-12-20 Process for production of medical compositions against tumour

Publications (1)

Publication Number Publication Date
NO853241L true NO853241L (no) 1985-08-16

Family

ID=10967718

Family Applications (1)

Application Number Title Priority Date Filing Date
NO853241A NO853241L (no) 1983-12-20 1985-08-16 Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse

Country Status (23)

Country Link
US (1) US5068240A (da)
EP (1) EP0165960B1 (da)
JP (1) JPS61500729A (da)
KR (1) KR850700108A (da)
AU (1) AU574754B2 (da)
BR (1) BR8407235A (da)
CA (1) CA1255231A (da)
DE (1) DE3477881D1 (da)
DK (1) DK168530B1 (da)
EG (1) EG17013A (da)
ES (1) ES8604490A1 (da)
FI (1) FI853199L (da)
GR (1) GR82477B (da)
HU (1) HU200093B (da)
IL (1) IL73825A0 (da)
IN (1) IN160438B (da)
IT (1) IT1177485B (da)
MA (1) MA20305A1 (da)
NO (1) NO853241L (da)
NZ (1) NZ210558A (da)
PT (1) PT79698B (da)
WO (1) WO1985002769A1 (da)
ZA (1) ZA849897B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4044728B2 (ja) 1997-07-15 2008-02-06 メディクエスト セラピューティックス インク 治療および診断薬剤としての新規なポリアミンアナログ
US7208528B1 (en) 1997-07-15 2007-04-24 Mediquest Therapeutics, Inc. Polyamine analogues as therapeutic and diagnostic agents
US6646149B1 (en) 1997-07-15 2003-11-11 Nicolaas M. J. Vermeulin Polyamine analogues as therapeutic and diagnostic agents
USRE43327E1 (en) 2001-01-08 2012-04-24 Aminex Therapeutics, Inc. Hydrophobic polyamine analogs and methods for their use
GB0425556D0 (en) * 2004-11-19 2004-12-22 Glaxo Group Ltd Novel compounds
HUP0900271A2 (hu) * 2009-04-30 2010-11-29 Adam Kovacs Levegõszûrõ betét védõmaszkhoz, illetve légkezelõ berendezésekhez széles hatásspektrumú gyógyászati kezelési és prevenciós eljárásokban történõ alkalmazásra
KR101308591B1 (ko) * 2010-12-30 2013-09-13 주식회사 삼양바이오팜 양이온성 지질을 포함하는 음이온성 약물 전달체 및 그 제조방법
RU2487122C1 (ru) * 2012-05-24 2013-07-10 Общество с ограниченной ответственностью Научно-производственное объединение "НИИПАВ" Способ получения алкилимидазолина
HUE052620T2 (hu) 2016-03-25 2021-05-28 Aminex Therapeutics Inc Biológiailag hozzáférhetõ poliaminok
JP2023545674A (ja) 2020-09-30 2023-10-31 アミネックス セラピューティクス， インコーポレイテッド ポリアミン輸送阻害剤およびｄｆｍｏの配合原薬
WO2024209060A1 (en) * 2023-04-07 2024-10-10 Université D'aix-Marseille Polyaminated fatty acids for use as potentiators of antibacterial activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1202M (fr) * 1960-05-09 1962-03-26 American Cyanamid Co Compositions d'amides.
US3085940A (en) * 1960-05-09 1963-04-16 American Cyanamid Co Nu, nu'-methylene-bis-amides for the suppression of tumors

Also Published As

Publication number Publication date
ZA849897B (en) 1985-08-28
PT79698B (en) 1987-01-15
AU574754B2 (en) 1988-07-14
JPS61500729A (ja) 1986-04-17
ES538852A0 (es) 1986-02-01
US5068240A (en) 1991-11-26
DK168530B1 (da) 1994-04-18
KR850700108A (ko) 1985-10-25
IT1177485B (it) 1987-08-26
GR82477B (en) 1985-04-11
BR8407235A (pt) 1985-11-26
FI853199A0 (fi) 1985-08-20
WO1985002769A1 (en) 1985-07-04
FI853199A7 (fi) 1985-08-20
AU3780185A (en) 1985-07-12
PT79698A (en) 1985-01-01
DK329985D0 (da) 1985-07-19
HU200093B (en) 1990-04-28
EG17013A (en) 1993-07-30
MA20305A1 (fr) 1985-07-01
ES8604490A1 (es) 1986-02-01
NZ210558A (en) 1988-04-29
IN160438B (da) 1987-07-11
DE3477881D1 (en) 1989-06-01
IT8424159A0 (it) 1984-12-20
FI853199L (fi) 1985-08-20
HUT39602A (en) 1986-10-29
EP0165960B1 (en) 1989-04-26
IL73825A0 (en) 1985-03-31
EP0165960A1 (en) 1986-01-02
DK329985A (da) 1985-07-19
CA1255231A (en) 1989-06-06

Similar Documents

Publication Publication Date Title
EP0196415B1 (en) Trichostatins a and c as antitumour drugs
Russell et al. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas
NO853241L (no) Farmasoeytiske antitumorpreparater og fremgngsmaate for fremstilling av disse
Patrick Reynolds et al. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant
Richardson et al. Action of polylysine on some ascites tumors in mice.
KR920002935B1 (ko) 맥관 형성 저해제
WO2006035244A9 (en) Ecteinascidin compounds as anti -inflammatory agents
Tobey et al. Effects of Bouvardin (NSC 259968), a cyclic hexapeptide from Bouvardia ternifolia, on the progression capacity of cultured Chinese hamster cells
DiPaolo et al. In Vitro Test Systems for Cancer Chemotherapy: I. Inhibition of Dehydrogenases and Growth in the Ehrlich Ascites Tumor
Okamoto et al. Elimination of leukemic cells by the combined use of ether lipids in vitro
Chu et al. Differential characteristics of two newly established human breast carcinoma cell lines
EP0179127B1 (en) Leukoregulin, an antitumor lymphokine, and its therapeutic uses
Bremerskov et al. DNA synthesis during the life cycle of L cells: Morphological, histochemical and biochemical investigations with arabinosylcytosine and thioarabinosylcytosine
Heidelberger et al. Studies on OPSPA: I. The Effect of Several Phosphoramides on Transplanted Tumors
CA1139219A (en) Medicinal preparation for treating carcinomas and process of producing the preparation
Wierda et al. Partial characterization of bone marrow hemopoiesis in mice after cisplatin administration
JPH06501024A (ja) 皮膚腫瘍形成を予防し、存在する腫瘍の後退の原因になるための医薬組成物と方法
Burns et al. Inhibition of marrow granulocytic colony formation by phytohemagglutinin
Blumenfeld et al. A chemotactic inhibitor produced by blast cells and present in the serum of a patient with acute lymphoblastic leukemia
Khan Acute myeloid leukemia with two philadelphia chromosomes in forty-six stemline: Remarks on the karyotypic analysis and chemotherapy
Hug et al. Chemosensitivities of human clonogenic breast tumor cells
Joshi et al. Modified Combination Chemotherapy of Leukemia: An Attempt to Overcome Drug Resistance
Fardon et al. The effect of a yeast extract (PCO) on the mitotic activity of neoplastic and normal cells in vitro
Chaplinski et al. Study of differentiation of fresh myeloid leukemic cells by physiologic agents that induce a human promyelocytic leukemic line (HL-60) to differentiate
CN113908168A (zh) 柳穿鱼叶苷在制备抗骨肉瘤药物中的应用及抗骨肉瘤药物制剂